As discussed above, TXL was also capable of regulating ubiquitin to adjust CRP level, and the active compounds of TXL were validated to be effective in regulating inflammation-related pathway, which further confirmed the theory of anti-inflammatory effects of TXL capsule on CHD patients. This evidence concerns the gene TXNL1 and coronary artery disorder.